Skip to content
Clinical Trials – home

Koranyi National Institute For Pulmonology

Verifiedinfo

Hungary Koranyi Frigyes Ut 1, 1121 Budapest, Hungary

  • 34 trials recruiting
  • Non-small cell lung cancer · Non-small cell lung cancer metastatic · Small cell lung cancer extensive stage
  • Adults and children

About Specializations

Koranyi National Institute For Pulmonology in Budapest, Hungary specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer metastatic, Small cell lung cancer extensive stage, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

The medical center is at the forefront of research in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease, focusing on innovative treatments to improve lung function.

  • Vixarelimab efficacy studies
  • Comparative analysis with placebo

Through rigorous clinical trials, the center is advancing therapeutic options for these challenging conditions, aiming to enhance patient outcomes and quality of life.

Small Cell Lung Cancer (SCLC)

Specializing in Small Cell Lung Cancer, the center is dedicated to improving survival rates through cutting-edge research and treatment comparisons.

  • Tarlatamab versus standard chemotherapy
  • Trilaciclib in extensive stage SCLC

By exploring novel therapeutic agents and their efficacy, the center contributes significantly to the advancement of SCLC treatment protocols.

Non-Small Cell Lung Cancer (NSCLC)

The center is a leader in Non-Small Cell Lung Cancer research, focusing on innovative therapies and treatment strategies for various stages and mutations.

  • Pembrolizumab and lenvatinib combination studies
  • Repotrectinib versus crizotinib trials
  • Adagrasib for KRAS G12C mutation

Through comprehensive clinical trials, the center is enhancing the understanding and management of NSCLC, offering hope for improved patient survival and quality of life.

Chronic Neuropathic Pain

Focusing on Chronic Neuropathic Pain, the center is pioneering research into effective pain management solutions for conditions like postherpetic neuralgia.

  • NT 201 injection efficacy
  • Placebo-controlled pain reduction studies

By investigating new therapeutic approaches, the center aims to provide relief and improve the quality of life for patients suffering from chronic pain.

Lung Cancer Diagnostics

The center is advancing the field of Lung Cancer diagnostics through innovative technologies designed to improve early detection and diagnostic accuracy.

  • OWL-EVO1 Breath Biopsy test
  • Diagnostic accuracy studies

By enhancing diagnostic tools, the center is contributing to earlier and more accurate detection of lung cancer, which is crucial for effective treatment and management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Koranyi Frigyes Ut 11121 BudapestHungary
Recruiting now
34 trials
Conditions studied
40
Partner status
Verified

More sites in BudapestHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

88 clinical trials

Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Bronchiectasis

Recruiting
Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Innate Pharma
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.